Vimarsana
Biggest News Aggregation in the World

Page 5 - Acceleron Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acceleron Pharma Today - Breaking & Trending Today

Aerovate Therapeutics Announces Full-Year 2023 Financial - Vimarsana News

Aerovate Therapeutics Announces Full-Year 2023 Financial

Topline data expected in June 2024 from Phase 2b portion of the IMPAHCT global Phase 2b/Phase 3 clinical trial of AV-101 for pulmonary arterial...

Bristol Myers Squibb Receives Positive CHMP Opinion for Reblozyl® (luspatercept) for Treatment of Adults with Transfusion-Dependent Anemia due to Low- to Intermediate-Risk Myelodysplastic Syndromes (MDS) - Vimarsana News

Bristol Myers Squibb Receives Positive CHMP Opinion for Reblozyl® (luspatercept) for Treatment of Adults with Transfusion-Dependent Anemia due to Low- to Intermediate-Risk Myelodysplastic Syndromes (MDS)

Approval by European Commission would expand Reblozyl’s indication to include first-line treatment of anemia in adults with MDS in Europe In the pivotal Phase 3 COMMANDS study, Reblozyl nearly...

Bristol Myers Gets CHMP Backing for Expanded Reblozyl Use - Vimarsana News

Bristol Myers Gets CHMP Backing for Expanded Reblozyl Use

By Colin Kellaher Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of its anemia drug Reblozyl. The...

Head-To-Head Review: Fulcrum Therapeutics (NASDAQ:FULC) versus Vertex Pharmaceuticals (NASDAQ:VRTX) - Vimarsana News

Head-To-Head Review: Fulcrum Therapeutics (NASDAQ:FULC) versus Vertex Pharmaceuticals (NASDAQ:VRTX)

Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report) and Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, valuation and profitability. Earnings and Valuation This table compares Fulcrum Therapeutics […]

Source: wkrb13.com
Reviewing Fulcrum Therapeutics (NASDAQ:FULC) & Vertex Pharmaceuticals (NASDAQ:VRTX) - Vimarsana News

Reviewing Fulcrum Therapeutics (NASDAQ:FULC) & Vertex Pharmaceuticals (NASDAQ:VRTX)

Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report) and Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, earnings, dividends, analyst recommendations, institutional ownership and valuation. Profitability This table compares Fulcrum Therapeutics and Vertex […]